Niels Riedemann - 18 Mar 2026 Form 3 Insider Report for InflaRx N.V. (IFRX)

Signature
/s/ Christian Schmid, Attorney-in-Fact
Issuer symbol
IFRX
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 08:06:59 UTC

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Riedemann Niels Chief Executive Officer, Director C/O INFLARX N.V., WINZERLAER STREET 2, JENA, GERMANY /s/ Christian Schmid, Attorney-in-Fact 18 Mar 2026 0001730827

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IFRX Ordinary Shares 1,068,908 18 Mar 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 126,005 $0.0152 Direct F1
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 404,040 $1.86 Direct F2
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 689,253 $1.86 Direct F3
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 5,409 $1.86 Direct F4
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 350,000 $1.86 Direct F5
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 112,007 $1.86 Direct F6
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 548,000 $1.86 Direct F7
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 55,000 $2.44 Direct F8
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 548,000 $2.37 Direct F9
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 635,000 $1.79 Direct F10
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 635,000 $2.41 Direct F11
holding IFRX Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 635,000 $1.17 Direct F12
holding IFRX Performance Stock Option (Right to Buy) 18 Mar 2026 Ordinary Shares 190,500 $1.17 Direct F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on November 15, 2012 and is fully vested and exercisable as of the date hereof.
F2 This option was granted on November 18, 2016 and is fully vested and exercisable as of the date hereof.
F3 This option was granted on December 13, 2017 and is fully vested and exercisable as of the date hereof.
F4 This option was granted on November 20, 2018 and is fully vested and exercisable as of the date hereof.
F5 This option was granted on January 4, 2021 and is fully vested and exercisable as of the date hereof.
F6 This option was granted on July 2, 2021 and is fully vested and exercisable as of the date hereof.
F7 This option was granted on January 12, 2022 and is fully vested and exercisable as of the date hereof.
F8 This option was granted on November 21, 2022 and is fully vested and exercisable as of the date hereof.
F9 This option was granted on January 24, 2023 and is fully vested and exercisable as of the date hereof.
F10 This option was granted on January 5, 2024 and is fully vested and exercisable as of the date hereof.
F11 This option was granted on January 3, 2025 and is fully vested and exercisable as of the date hereof.
F12 This option was granted on January 6, 2026 and will vest and become exercisable in four equal installments of 158,750 shares on each quarterly anniversary of such grant date, subject to continued service through such dates.
F13 This option shall vest depending upon achievement of the following performance criteria: (i) 50% shall vest if a certain financing event takes place before the fourth quarter of 2026 and (ii) 50% shall vest if the average Ordinary Share price for quarter four of 2026 exceeds $1.50.

Remarks:

Exhibit List - Exhibit 24.1 Power of Attorney